Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry

Cell Rep. 2022 Feb 1;38(5):110296. doi: 10.1016/j.celrep.2022.110296.

Abstract

Here, we present ultrastructural analyses showing that incoming HIV are captured near the lymphocyte surface in a virion-glycan-dependent manner. Biophysical analyses show that removal of either virion- or cell-associated N-glycans impairs virus-cell binding, and a similar glycan-dependent relationship is observed between purified HIV envelope (Env) and primary T cells. Trimming of N-glycans from either HIV or Env does not inhibit protein-protein interactions. Glycan arrays reveal HIV preferentially binds to N-acetylglucosamine and mannose. Interfering with these glycan-based interactions reduces HIV infectivity. These glycan interactions are distinct from previously reported glycan-lectin and non-specific electrostatic charge-based interactions. Specific glycan-glycan-mediated attachment occurs prior to virus entry and enhances efficiency of infection. Binding and fluorescent imaging data support glycan-glycan interactions as being responsible, at least in part, for initiating contact between HIV and the host cell, prior to viral Env-cellular CD4 engagement.

Keywords: HIV; adhesion; attachment; glycan-glycan interaction; glycocalyx; non-electrostatic; virus entry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / metabolism
  • Cell Membrane / metabolism
  • Glycosylation / drug effects
  • HIV Antibodies / metabolism
  • HIV Antibodies / pharmacology*
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • HIV-1 / drug effects
  • HIV-1 / immunology
  • Humans
  • Polysaccharides / metabolism*
  • Virion / metabolism
  • Virus Internalization / drug effects*
  • env Gene Products, Human Immunodeficiency Virus / chemistry

Substances

  • Antibodies, Neutralizing
  • HIV Antibodies
  • Polysaccharides
  • env Gene Products, Human Immunodeficiency Virus